Global Biosimilar Growth Hormones Market Segments

The global biosimilar growth hormones market is expected to decline from $0.55 billion in 2019 to $0.53 billion in 2020 at a compound annual growth rate (CAGR) of -2.92%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $0.69 billion in 2023 at a CAGR of 9.07%. The growing number of children suffering from growth hormone deficiency is driving the growth of the global biosimilar growth hormone market. However, the growing awareness about the side effects caused by the continuous usage of the biosimilar growth hormones is expected to restrict the growth of the market.

The biosimilar growth hormone market consists of sales of Somatropin or human growth hormone (HGH) and related services by entities that manufacture growth hormones. Biosimilar growth hormones are used to stimulate growth, cell reproduction and cell regeneration in humans and other animals.

Request For A Free Sample For The Global Biosimilar Growth Hormones Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp

The global biosimilar growth hormones market is further segmented based on type and geography.
By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Others
By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Speciality Clinics
By Geography: The global biosimilar growth hormones market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North American biosimilar growth hormones market accounts for the largest share in the global biosimilar growth hormones market.

Read More On The Report For The Global Biosimilar Growth Hormones Market At:
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormones-market-global-report-2020-30-covid-19-growth-and-change

Trends In The Biosimilar Growth Hormones Market
Recombinant DNA technology (rDNA technology) is increasingly being implemented in the biosimilar growth hormone industry. The development of biosimilar growth hormone by using rDNA technology is an emerging trend.
Biosimilar Growth Hormones Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides biosimilar growth hormones market overviews, analyzes and forecasts biosimilar growth hormones market size and growth for the global biosimilar growth hormones market, biosimilar growth hormones market share, biosimilar growth hormones market players, biosimilar growth hormones market size, biosimilar growth hormones market segments and geographies, biosimilar growth hormones market trends, biosimilar growth hormones market drivers and biosimilar growth hormones market restraints, biosimilar growth hormones market’s leading competitors’ revenues, profiles and market shares. The biosimilar growth hormones market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)